Expression of bFGF in malignant tumor and its clinical pathological sig-nificance
10.3969/j.issn.1000-4718.2015.04.003
- VernacularTitle:bFGF 在恶性肿瘤中的表达及其临床病理意义
- Author:
Jianfu ZHAO
;
Meng XU
;
Fengzhi ZHAO
;
Penghui HU
;
Qiang QUAN
;
Junjian XIANG
;
Hong WANG
- Publication Type:Journal Article
- Keywords:
Malignant tumor;
Basic fibroblast growth factor;
Clinical pathological characteristics
- From:
Chinese Journal of Pathophysiology
2015;33(4):590-596
- CountryChina
- Language:Chinese
-
Abstract:
[ ABSTRACT] AIM: To detect basic fibroblast growth factor ( bFGF ) expression in clinical common malignant tumor ( non-small-cell lung cancer,breast cancer, colon cancer and melanoma) , and to identify relationship between the expression and tumor clinicopathological characteristics.METHODS:Immunohistochemical SP method was used to detect the expression of bFGF at protein level in 208 cases of paraffin-embedded tissue of primary malignant tumor patients ( 68 cases of lung cancer, 80 cases of breast carcinoma, 41 cases of colon cancer and 19 cases of melanoma) .RESULTS:The bFGF protein expression levels were significantly higher in low differentiated non-small-cell lung cancer with lymph node metastasis, and were positively correlated with TNM.In addition, no significant influence of the bFGF protein expression on the patients with median survival period was observed.The protein expression of bFGF was higher in advanced breast cancer with lymph node metastasis and was commonly found in the middle/higher differentiated colon cancer with regional lymph node metastasis.Meanwhile, bFGF protein was highly expressed in advanced melanoma patients with lymph node metastasis.CONCLUSION:bFGF may participate in the process of occurrence and progression of malignant tumor.Ex-pression of bFGF protein may be an effective parameter for evaluating metastasis and prognosis of malignant tumor.
